Status:
RECRUITING
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Advocates for Human Potential
Conditions:
Cannabis Use
THC
Eligibility:
All Genders
21-25 years
Phase:
NA
Brief Summary
The goal of this interventional study is to determine the impact of high potency THC product use on cognitive function of young adults aged 21-25. The main question it aims to answer is: will cannabi...
Detailed Description
The goal of this interventional study is to determine the impact of high potency THC product use on cognitive function of young adults aged 21-25. The aims aims of this study are: 1. Evaluate feasib...
Eligibility Criteria
Inclusion
- Between the ages of 21-25
- Resides in San Francisco
- Self-report cannabis concentrate use as their primary method of cannabis use
- Self-report using cannabis daily or almost daily (i.e., at least 6 out of 7 days during each of the last 4 weeks)
- Self-report only purchasing cannabis from regulated retail stores in California.
Exclusion
- Pregnant
- Regularly uses other drugs (other than nicotine)
Key Trial Info
Start Date :
March 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 14 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06077292
Start Date
March 17 2025
End Date
March 14 2026
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143